Filing Details
- Accession Number:
- 0001209191-19-027964
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-07 16:12:38
- Reporting Period:
- 2019-05-03
- Accepted Time:
- 2019-05-07 16:12:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1708493 | Harpoon Therapeutics Inc. | HARP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1290747 | Phd Gerald Mcmahon | C/O Harpoon Therapeutics, Inc. 4000 Shoreline Court, Suite 250 South San Francisco CA 94080 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-03 | 1,000 | $10.53 | 1,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $10.510 to $10.546 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.